NYSE:NUS - Nu Skin Enterprises Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$70.51 +1.74 (+2.53 %)
(As of 10/16/2018 04:00 PM ET)
Previous Close$68.77
Today's Range$68.50 - $70.60
52-Week Range$59.31 - $88.68
Volume393,937 shs
Average Volume468,196 shs
Market Capitalization$4.58 billion
P/E Ratio21.39
Dividend Yield2.13%
Beta1.06
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:NUS
CUSIP67018T10
Phone801-345-1000

Debt

Debt-to-Equity Ratio0.46
Current Ratio1.82
Quick Ratio1.19

Price-To-Earnings

Trailing P/E Ratio21.39
Forward P/E Ratio19.53
P/E Growth2.35

Sales & Book Value

Annual Sales$2.28 billion
Price / Sales1.72
Cash Flow$4.0453 per share
Price / Cash17.43
Book Value$13.40 per share
Price / Book5.26

Profitability

EPS (Most Recent Fiscal Year)$3.23
Net Income$129.43 million
Net Margins5.74%
Return on Equity25.67%
Return on Assets11.66%

Miscellaneous

Employees4,700
Outstanding Shares55,610,000
Market Cap$4.58 billion

Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Friday, August 3rd. Stockholders of record on Friday, August 31st will be paid a dividend of $0.365 per share on Wednesday, September 12th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date is Thursday, August 30th. View Nu Skin Enterprises' Dividend History.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings data on Thursday, August, 2nd. The company reported $1.08 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.18. The business had revenue of $704.19 million for the quarter, compared to analyst estimates of $642.16 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. Nu Skin Enterprises's revenue was up 28.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 EPS. View Nu Skin Enterprises' Earnings History.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Wednesday, November 7th 2018. View Earnings Estimates for Nu Skin Enterprises.

How can I listen to Nu Skin Enterprises' earnings call?

Nu Skin Enterprises will be holding an earnings conference call on Wednesday, November 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided EPS guidance of $3.66-3.81 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.72. The company issued revenue guidance of $2.63-2.67 billion, compared to the consensus revenue estimate of $2.53 billion.Nu Skin Enterprises also updated its Q3 guidance to $0.97-1.02 EPS.

What price target have analysts set for NUS?

6 brokers have issued 1 year price objectives for Nu Skin Enterprises' shares. Their forecasts range from $70.00 to $98.00. On average, they expect Nu Skin Enterprises' stock price to reach $84.8333 in the next year. This suggests a possible upside of 20.3% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.

What is the consensus analysts' recommendation for Nu Skin Enterprises?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nu Skin Enterprises.

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. According to Zacks Investment Research, "Nu Skin’s shares have declined and underperformed the industry in the past month. The company has been struggling with declining gross margins for a while. Persistent declines in gross margin levels pose considerable threats for the company’s overall profitability. Moreover, Nu Skin remains exposed to significant currency risks resulting from international markets and stiff competition from the existence of strong peers and abundant product alternatives. Nonetheless, strong regional performance, as well as expanding sales leaders and customers bode well for the company. Notably, these upsides aided the company’s second-quarter 2018 results, marking its third consecutive period of year-on-year top- and bottom-line increases. To sustain such solid trends, Nu Skin is on track with initiatives to enhance technological capabilities, along with well-knit product launches and marketing programs." (10/15/2018)
  • 2. Jefferies Financial Group Inc analysts commented, "We hosted NUS senior leaders for a series of meetings last week. While our view of China macro beauty has tempered somewhat in recent months, we walked away from meetings with a more optimistic sense of China skincare device sales potential and global benefits from product innovation (new & extensions), program enhancements (including sales comp structure), and a growing level of sophistication around social selling that sets NUS apart from other MLM companies." (9/4/2018)
  • 3. Pivotal Research analysts commented, "We think 2018 might be bigger than usual – for Repo which again, is not in guidance." (2/16/2018)

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a decrease in short interest in the month of September. As of September 14th, there was short interest totalling 1,748,580 shares, a decrease of 25.0% from the August 31st total of 2,332,537 shares. Based on an average trading volume of 405,157 shares, the short-interest ratio is currently 4.3 days. Approximately 3.2% of the shares of the stock are short sold. View Nu Skin Enterprises' Current Options Chain.

Who are some of Nu Skin Enterprises' key competitors?

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the folowing people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 65)
  • Mr. Ritch N. Wood, CEO & Director (Age 52)
  • Mr. Ryan S. Napierski, Pres (Age 44)
  • Mr. Mark H. Lawrence, Exec. VP & CFO
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 65)

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.02%), Fox Run Management L.L.C. (0.01%) and First Hawaiian Bank (0.00%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Daniel W Campbell, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

Which major investors are buying Nu Skin Enterprises stock?

NUS stock was bought by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C., State of Alaska Department of Revenue and First Hawaiian Bank. View Insider Buying and Selling for Nu Skin Enterprises.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $70.51.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $4.58 billion and generates $2.28 billion in revenue each year. The company earns $129.43 million in net income (profit) each year or $3.23 on an earnings per share basis. Nu Skin Enterprises employs 4,700 workers across the globe.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is http://www.nuskinenterprises.com.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]


MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  408 (Vote Outperform)
Underperform Votes:  364 (Vote Underperform)
Total Votes:  772
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel